Ohr Pharmaceutical Inc 4
Accession 0001387131-16-005686
Filed
May 24, 8:00 PM ET
Accepted
May 25, 1:25 PM ET
Size
45.6 KB
Accession
0001387131-16-005686
Insider Transaction Report
- Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.23/sh+1,337$4,319→ 885,841 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.20/sh+446$1,427→ 887,892 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.21/sh+1,516$4,866→ 887,446 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.19/sh+1,248$3,981→ 889,140 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.17/sh+6,851$21,718→ 897,579 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.08/sh+1,600$4,928→ 908,069 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.09/sh+700$2,163→ 908,769 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.08/sh+100$309→ 911,464 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.07/sh+8$25→ 911,472 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.18/sh+1,588$5,050→ 890,728 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.16/sh+3,121$9,862→ 900,700 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.16/sh+100$316→ 906,069 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.15/sh+200$630→ 906,269 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.06/sh+800$2,448→ 912,272 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.22/sh+89$287→ 885,930 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.15/sh+1,516$4,775→ 902,216 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.14/sh+357$1,121→ 902,573 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.13/sh+803$2,513→ 903,376 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.13/sh+89$278→ 903,465 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.12/sh+1,337$4,171→ 904,802 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.11/sh+267$830→ 905,069 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.13/sh+200$626→ 905,269 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.14/sh+200$628→ 905,469 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.17/sh+500$1,585→ 905,969 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.12/sh+200$624→ 906,469 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.07/sh+2,595$7,967→ 911,364 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-24$3.10/sh+300$930→ 912,572 total
- 697,865(indirect: By LLC)
Common Stock, par value $0.0001 per share
Footnotes (1)
- [F1]SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestone 1 has been met and on December 15, 2015, the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein.
Documents
Issuer
Ohr Pharmaceutical Inc
CIK 0001173281
Related Parties
1- filerCIK 0001173281
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 1:25 PM ET
- Size
- 45.6 KB